Holden Stuart has filed 5 insider transactions across 1 company since August 2024.
Most recent transaction: a option exercise of 2000 shares of UroGen Pharma Ltd. ($URGN) on November 26, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 26, 2025 | UroGen Pharma Ltd. | $URGN | Holden Stuart | Director | M | ordinary shares | 2000 | $0.00 | 2,000.0000 | 48,057,386 | 9999.99% | 0.00% |
| Nov. 26, 2025 | UroGen Pharma Ltd. | $URGN | Holden Stuart | Director | M | Restricted Stock Unit | 2000 | $0.00 | 6,000.0000 | 48,057,386 | 25.00% | 0.00% |
| Aug. 26, 2025 | UroGen Pharma Ltd. | $URGN | Holden Stuart | Director | A | Stock Option (right ot buy) | 10000 | $0.00 | 10,000.0000 | 47,030,820 | 9999.99% | 0.02% |
| Aug. 26, 2025 | UroGen Pharma Ltd. | $URGN | Holden Stuart | Director | A | Restricted Stock Unit | 8000 | $0.00 | 8,000.0000 | 47,030,820 | 9999.99% | 0.02% |
| Aug. 6, 2024 | UroGen Pharma Ltd. | $URGN | Holden Stuart | Director | A | Stock Option (right ot buy) | 10000 | $0.00 | 10,000.0000 | 40,501,315 | 9999.99% | 0.02% |